Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

DepoTech seeks Canadian approval for DepoCyt

Sep. 4, 1997

AccuSite approved in Ireland and The Netherlands

Sep. 4, 1997

Vitronectin receptor antagonists described by Merck KGaA

Sep. 4, 1997

Cloning of telomerase catalytic subunit reported

Sep. 3, 1997

Merck & Co. describes nonsteroidal antiandrogen

Sep. 3, 1997

U.S. clearance for Femara

Sep. 2, 1997

Development update on Oncolym

Sep. 2, 1997

Small peptides developed at Prolifix induce apoptosis in cancer cells

Sep. 1, 1997

ArQule and GenQuest cancer collaboration

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...